Home Medical stocks European stocks and Dow futures fall as Goldman slashes GDP view, citing...

European stocks and Dow futures fall as Goldman slashes GDP view, citing lack of stimulus


A woman rides a bicycle past a red light in Paris on September 23, 2020.

christophe archambault/Agence France-Presse/Getty Images

European stocks dropped and U.S. stock futures weakened Thursday, as investors have largely given up on the idea that the U.S. Congress will provide new stimulus while worrying about a recent rise in COVID-19 cases.

After a 0.6% advance on Wednesday, the Stoxx Europe 600

fell 0.9%. The aviation sector had another rough day, with International Airlines Group

and Deutsche Lufthansa

all retreating.

The German DAX
French CAC 40

and U.K. FTSE 100

each declined.

U.S. stocks had a rough Wednesday, with the Dow Jones Industrial Average

retreating 525 points. Stock futures


were lower on Thursday as well.

Economists at Goldman Sachs cut their U.S. growth forecast for the fourth quarter in half, to 3% from 6%. “We think it is now clear that Congress will not attach additional fiscal stimulus to the continuing resolution. This implies that after a final round of extra unemployment benefits that is currently being disbursed, any further fiscal support will likely have to wait until 2021,” the economists said. The continuing resolution is a reference to the extension of funding beyond the September-ending fiscal year, which the U.S. House has already passed.

Ajay Rajadhyaksha, a New York-based strategist for U.K. bank Barclays, told clients that “the valuation gap between growth and value equities is now at such an extreme that value stocks offer positive asymmetry on the next leg of the recovery, which should help European and other non-U.S. indices.”

Of stocks on the move, Suez

shares fell 5% after its board of directors announced moves that seek to prevent a sale of its water subsidiary Suez Eau France, as part of Suez’s broader resistance to a a takeover from Veolia Environnement

Smiths Group

shares dropped 6%. The U.K. engineering group reinstated its dividend as its pretax profit from continuing operations due to the planned separation of Smiths Medical.

Pets At Home

shares rose 10% as the U.K. pet supplies retailer said underlying pretax profits would be ahead of the £73 million pound consensus. It said it had double-digit like-for-like sales growth through the eight weeks to Sept. 10.


This site uses Akismet to reduce spam. Learn how your comment data is processed.